| Literature DB >> 17173115 |
Raman Chawla, Rajesh Arora, Shikha Singh, R K Sagar, Rakesh Kumar Sharma, R Kumar, A Sharma, R P Tripathi, S C Puri, H A Khan, A S Shawl, P Sultan, Tej Krishan, G N Qazi.
Abstract
We have evaluated the effect of variation in aryl-tetralin lignans on the radioprotective properties of Podophyllum hexandrum. Two fractionated fractions of P. hexandrum [methanolic (S1) and chloroform fractions (S2)], with varying aryl-tetralin lignan content were utilized for the present study. The peroxyl ion scavenging potentials of S1 and S2 were found to be comparable [i.e. 45.88% (S1) and 41% (S2)] after a 48 h interval in a time-dependent study, whereas in a 2 h study, S2 exhibited significant (P < 0.05) antioxidant activity in different metal ion + flux states. In the aqueous phase, S2 exhibited non-site-specific reactive oxygen species scavenging activity, i.e. 73.12% inhibition at 500 mug ml(-1). S1 exhibited 58.40 +/- 0.8% inhibition (at 0.025 mug ml(-1)) of the formation of reactive nitrite radicals, comparable to S2 (52.45 +/- 0.825%), and also showed 45.01% site-specific activity (1000 mug ml(-1)), along with significant (P < 0.05) electron donation potential (50-2000 mug ml(-1)) compared to S2. Such activities of S1 could be attributed to the significantly (P < 0.05) higher levels of podophyllotoxin beta-d-glucopyranoside (16.5 times) and demethyl podophyllotoxin glucoside (2.9 times) compared with S2. Together, these findings clearly prove that aryl-tetralin lignan content influences the radiation protective potential of the Podophyllum fractions to a great extent.Entities:
Year: 2006 PMID: 17173115 PMCID: PMC1697744 DOI: 10.1093/ecam/nel037
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Parent compound of family of aryl-tetralin lignans. (a) Podophyllotoxin skeleton. (b) HPLC profile of S1 (gradient analysis) and (c) HPLC profile of S2 (gradient analysis).
Figure 2(a) Antioxidant activity of S1 in the lipid phase (time-dependent study; radiation dose: 0.25 kGy). (b) Antioxidant activity of S2 in lipid phase (time-dependent study; radiation dose: 0.25 kGy). ‘a–g’ represents the results of Tukey's HSD test and significant difference. *P < 0.05 for variation between fractions.
Aryl-tetralin lignans present in S1 and S2 fractions
| S. no | Phyto-constituents identified | Relative percentage of the major constituents | Relative ratio of the lignans in S1/S2 | |
|---|---|---|---|---|
| S1 | S2 | |||
| 1 | 4-Demethyl podophyllotoxin glycoside | 5.843573 | 27.02068 | 2.93 |
| 2 | Podophyllotoxin-β- | 51.39492 | 42.02375 | 16.58 |
| 3 | Podophyllotoxin | 27.50243 | 14.26229 | 26.14 |
| 4 | 4-Demethyl deoxy podophyllotoxin | 14.0032 | 5.533672 | 34.31 |
| 5 | Picropodophyllotoxin | 0 | 0 | 0 |
| 6 | Isopicropodophyllotoxin | 0.714151 | 6.551496 | 1.47 |
| 7 | Deoxypodophyllotoxin | 0.541736 | 4.608124 | 1.59 |
Pro-oxidant–antioxidant activity of S1 and S2 in the lipid phase
| Activity | Pro-oxidant | Antioxidant | ||
|---|---|---|---|---|
| Stress | Untreated | |||
| Concentration | +flux | −flux | +flux | −flux |
| S1 fraction | ||||
| 1 | – | – | 7.5 | 7.3* |
| 2.5 | – | – | 13.2 | 8.6* |
| 5 | – | – | 28.19 | 50.8* |
| 10 | – | – | 29.5 | 8.3 |
| S2 fraction | ||||
| 1 | – | 89.14 | 30.76* | – |
| 2.5 | – | 86.8 | 54.08* | – |
| 5 | – | 78.7 | 48.55* | – |
| 10 | – | 4.52 | 41.34* | – |
+flux, stress +0.25 kGy; −flux, stress only; *significant antioxidant activity at P < 0.05 with respect to respective stress ± flux control of the other fraction (S1 versus S2).
Pro-oxidant–antioxidant activity of S1 and S2 in the lipid phase [Fe(II)]
| Activity | Pro-oxidant | Antioxidant | ||
|---|---|---|---|---|
| Stress | Fe(II) | |||
| Concentration | +flux | −flux | +flux | −flux |
| S1 fraction | ||||
| 1 | – | – | 3.28 | 41.59* |
| 2.5 | – | – | 35.7 | 47.7* |
| 5 | – | 17.6 | 22.6 | – |
| 10 | – | 28.8 | 18.8 | – |
| S2 fraction | ||||
| 1 | – | – | 2.132 | 10.98 |
| 2.5 | – | – | 36.24 | 20.56 |
| 5 | – | – | 17.69 | 34.64* |
| 10 | – | 16.6 | 13.8 | – |
+flux, stress +0.25 kGy; −flux, Stress only; *significant antioxidant activity at P < 0.05 with respect to respective stress ± flux control of the other fraction (S1 versus S2).
Pro-oxidant–antioxidant activity of S1 and S2 in the lipid phase [Fe(III)]
| Activity | Pro-oxidant | Antioxidant | ||
|---|---|---|---|---|
| Stress | Fe(III) | |||
| Concentration | +flux | −flux | +flux | −flux |
| S1 fraction | ||||
| 1 | 1.7 | 49.7 | – | – |
| 2.5 | 25.1 | 79.2 | – | – |
| 5 | – | 16.4 | 13.9 | – |
| 10 | – | 19.6 | 24.17 | – |
| S2 fraction | ||||
| 1 | – | 50.4 | 20* | – |
| 2.5 | – | 49.3 | 21.8* | – |
| 5 | – | 2.96 | 77.4* | – |
| 10 | – | 3.5 | 77.9* | – |
+flux, stress +0.25 kGy; −flux, Stress only; *significant antioxidant activity at P < 0.05 with respect to respective stress ± flux control of the other fraction (S1 versus S2).
Pro-oxidant–antioxidant activity of S1 and S2 in the lipid phase [Cu(II)]
| Activity | Pro-oxidant | Antioxidant | ||
|---|---|---|---|---|
| Stress | Cu(II) | |||
| Concentration | +flux | −flux | +flux | −flux |
| S1 fraction | ||||
| 1 | – | – | 1.6* | 14.4* |
| 2.5 | – | – | 33.57* | 15.2* |
| 5 | – | – | 4.83 | 2.2 |
| 10 | – | 4.9 | 0.96 | – |
| S2 fraction | ||||
| 1 | 33.4 | – | – | 5.3 |
| 2.5 | 2.3 | 13.2 | – | – |
| 5 | – | 58.1 | 64.2* | – |
| 10 | – | 79.7 | 55.4* | – |
+flux, stress +0.25 kGy; −flux, stress only; *significant antioxidant activity at P < 0.05 with respect to respective stress ± flux control of the other fraction (S1 versus S2).
Figure 3ROS quenching potential. (a) Site-specific hydroxyl ion scavenging potential of S1 and S2. (b) Non-site-specific hydroxyl ion scavenging potential of S1 and S2. *Values represent a significant difference at P < 0.05.
Figure 4RNS quenching potential (percentage inhibition) of S1 and S2. *Values represent a significant difference at P < 0.05.
Figure 5Electron donation potential of S1 and S2 recorded as the optical density of the complex at 700 nm. *Values represent a significant difference in absorbance (P < 0.05) with respect to the other fraction.